-
Product Insights
SF Akaiwa Solar Power Plant
SF Akaiwa Solar Power Plant is a solar PV project located in Okayama, Japan. The project is owned and developed by JFE Technos Co., Ltd.; RS Renewables KK. The project came online in 2021. Empower your strategies with our SF Akaiwa Solar Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
SF Levante Solar PV Park
SF Levante Solar PV Park is a solar PV project located in Castile and León, Spain. The project is owned by Actividades de Construccion y Servicios SA; Galp Energia Espana SA and is developed by Cobra Instalaciones y Servicios SA; Galp Energia Espana SA. The project is at the permitting stage. Empower your strategies with our SF Levante Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request....
-
Product Insights
SF South Foggia Solar PV Park
SF South Foggia Solar PV Park is a solar PV project located in Apulia, Italy. The project is owned and being developed by TSK Electronica y Electricidad SA. The project is at the permitting stage. Empower your strategies with our SF South Foggia Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Company Insights
Innovation and Patenting activity of SFS Group AG Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of SFS Group AG Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewAesthetic Injectables Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Aesthetic Injectables Pipeline Market Report Overview Aesthetic injectables are gel-like substances injected beneath the skin to restore a youthful appearance by increasing the volume of sunken cheeks or temples or reducing lines around the nose and mouth, among other processes. Aesthetic Injectables are grouped into segments based on their molecular composition. The aesthetic injectables pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Company Insights
Innovation and Patenting activity of SF Holdings Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of SF Holdings Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Sector Analysis
Sweden Power Market Outlook to 2035 – Market Trends, Regulations and Competitive Landscape
Sweden Power Market Report Overview The annual power consumption in Sweden was 124.2 Terawatt hours (TWh) in 2022 and will grow at a CAGR of more than 1% during 2022-2035. The following are some of the key highlights of the Sweden power market: Industrial and residential sectors are key contributing factors. Majority of Sweden’s annual power generation comes from clean energy, hence, it exports surplus electricity Finland and Lithuania are the major countries to which Sweden exports electricity. Sweden mainly...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OTT-166 in Diabetic Macular Edema
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OTT-166 in Diabetic Macular Edema Drug Details: SF-0166 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OTT-166 in Proliferative Diabetic Retinopathy (PDR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTT-166 in Proliferative Diabetic Retinopathy (PDR) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OTT-166 in Proliferative Diabetic Retinopathy (PDR) Drug Details: SF-0166...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OTT-166 in Non-Proliferative Diabetic Retinopathy (NPDR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTT-166 in Non-Proliferative Diabetic Retinopathy (NPDR) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OTT-166 in Non-Proliferative Diabetic Retinopathy (NPDR) Drug Details: SF-0166...